SRPT - Sarepta Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

SRPT is currently covered by 13 analysts with an average price target of $22.67. This is a potential upside of $16.7 (12.56%) from yesterday's end of day stock price of $20.14.

Sarepta Therapeutics's activity chart (see below) currently has 652 price targets and 594 ratings on display. The stock rating distribution of SRPT is 40% HOLD, 30% BUY and 30% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 47.47% with an average time for these price targets to be met of 224.24 days.

Highest price target for SRPT is $37, Lowest price target is $13, average price target is $22.67.

Most recent stock forecast was given by BIREN AMIN from PIPER SANDLER on 09-Jul-2026. First documented stock forecast 20-Mar-2013.

Best performing analysts who are covering SRPT - Sarepta Therapeutics:

Difei Yang Gil Blum Simos Simeonidis Uy Ear Brian Abrahams Joel Beatty

Currently out of the existing stock ratings of SRPT, 8 are a HOLD (40%), 6 are a BUY (30%), 6 are a SELL (30%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 23-Jun-2025

$20

$-0.11 (-0.55%)

$16

2 months 13 days ago
(09-Jul-2026)

7/17 (41.18%)

$-0.52 (-2.53%)

71

Sell Since 24-Jul-2025

$13

$-3.85 (-22.85%)

5 months 27 days ago
(26-Mar-2026)

0/2 (0%)

$-8.68 (-40.04%)

Sell Since 22-Jul-2025

5 months 27 days ago
(26-Mar-2026)

14/35 (40%)

$28.03 (127.58%)

364

Buy Since 19-Mar-2026

$37

$20.15 (119.58%)

$50

6 months 3 days ago
(19-Mar-2026)

0/16 (0%)

$20.35 (122.22%)

Buy Since 13-Mar-2026

$31

$14.15 (83.98%)

$19

6 months 9 days ago
(13-Mar-2026)

4/14 (28.57%)

$14.6 (89.02%)

322

Show more analysts

Please expand the browser size to see the chart

What is SRPT (Sarepta Therapeutics) average time for price targets to be met?

On average it took 224 days for the stock forecasts to be reached, with an average price target met ratio of 47.47%.

Which analyst most recently updated their price target on SRPT (Sarepta Therapeutics)?

Biren Amin

Which analyst has the most public recommendations on SRPT (Sarepta Therapeutics)?

Biren Amin works at PIPER SANDLER and has 5 price targets and 5 ratings on SRPT

Which analyst is the currently most bullish on SRPT (Sarepta Therapeutics)?

Christopher Marai with the highest potential upside of $208.82

Which analyst is the currently most reserved on SRPT (Sarepta Therapeutics)?

Steve Brozak with the lowest potential downside of -$79.57

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?